A Phase 2 efficacy Proof of concept clinical trial of KH-001.
Latest Information Update: 05 Nov 2024
Price :
$35 *
At a glance
- Drugs KH 001 (Primary)
- Indications Premature ejaculation
- Focus Proof of concept; Therapeutic Use
- 05 Nov 2024 New trial record
- 10 Oct 2024 According to Kadence Bio Media Release, Company is planned to be initiated in 2025.